Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L N Horowitz

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
Clinical Pharmacology and Therapeutics|June 1, 1985
Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmiaL N Horowitz, A M Greenspan, S R Spielman, et al.
Journal of the American College of Cardiology|July 1, 1987
Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmiaT J Waller, H R Kay, S R Spielman, et al.
The American Journal of Cardiology|May 1, 1988
Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery diseaseM D Meissner, H R Kay, L N Horowitz, et al.
Journal of the American College of Cardiology|August 1, 1985
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapyA P Rae, N M Sokoloff, C R Webb, et al.
Circulation|September 1, 1983
Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originatesJ J Fenoglio, T D Pham, A H Harken, et al.
The American Journal of Cardiology|August 1, 1985
Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery diseaseA M Greenspan, S R Spielman, C R Webb, et al.
The American Journal of Cardiology|August 1, 1987
Determinants of hospital cost and length of stay for patients undergoing electrophysiologic testingH R Kay, L N Horowitz, H Goldstein, et al.
Journal of the American College of Cardiology|September 1, 1983
Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activityJ R Wilson, J S Schwartz, M S Sutton, et al.
Pacing and Clinical Electrophysiology : PACE|February 1, 1991
Device interaction--antitachycardia pacemakers and defibrillators for sustained ventricular tachycardiaT S Ahern, C Nydegger, D J McCormick, et al.
The American Journal of Cardiology|August 1, 1987
Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodaroneA A De Paola, L N Horowitz, S R Spielman, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|June 1, 1985
Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmiaL N Horowitz, A M Greenspan, S R Spielman, et al.
Journal of the American College of Cardiology|July 1, 1987
Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmiaT J Waller, H R Kay, S R Spielman, et al.
The American Journal of Cardiology|May 1, 1988
Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery diseaseM D Meissner, H R Kay, L N Horowitz, et al.
Journal of the American College of Cardiology|August 1, 1985
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapyA P Rae, N M Sokoloff, C R Webb, et al.
Circulation|September 1, 1983
Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originatesJ J Fenoglio, T D Pham, A H Harken, et al.
The American Journal of Cardiology|August 1, 1985
Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery diseaseA M Greenspan, S R Spielman, C R Webb, et al.
The American Journal of Cardiology|August 1, 1987
Determinants of hospital cost and length of stay for patients undergoing electrophysiologic testingH R Kay, L N Horowitz, H Goldstein, et al.
Journal of the American College of Cardiology|September 1, 1983
Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activityJ R Wilson, J S Schwartz, M S Sutton, et al.
Pacing and Clinical Electrophysiology : PACE|February 1, 1991
Device interaction--antitachycardia pacemakers and defibrillators for sustained ventricular tachycardiaT S Ahern, C Nydegger, D J McCormick, et al.
The American Journal of Cardiology|August 1, 1987
Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodaroneA A De Paola, L N Horowitz, S R Spielman, et al.
Pageof 16